nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—PTGS2—colon cancer	0.654	1	CbGaD
Drospirenone—BCHE—Irinotecan—colon cancer	0.112	1	CbGbCtD
Drospirenone—AR—scrotum—colon cancer	0.0236	0.286	CbGeAlD
Drospirenone—Thromboembolic event—Irinotecan—colon cancer	0.00703	0.0864	CcSEcCtD
Drospirenone—Cerebral infarction—Vincristine—colon cancer	0.00597	0.0733	CcSEcCtD
Drospirenone—Cerebral infarction—Irinotecan—colon cancer	0.00581	0.0714	CcSEcCtD
Drospirenone—PGR—blood vessel—colon cancer	0.00482	0.0583	CbGeAlD
Drospirenone—Thromboembolic event—Capecitabine—colon cancer	0.00471	0.0578	CcSEcCtD
Drospirenone—Infarction—Capecitabine—colon cancer	0.00457	0.0561	CcSEcCtD
Drospirenone—AR—Regulation of Androgen receptor activity—SPDEF—colon cancer	0.00438	0.0635	CbGpPWpGaD
Drospirenone—Thromboembolic event—Methotrexate—colon cancer	0.0035	0.0431	CcSEcCtD
Drospirenone—NR3C2—Preimplantation Embryo—CDX2—colon cancer	0.0035	0.0507	CbGpPWpGaD
Drospirenone—Embolism—Irinotecan—colon cancer	0.00295	0.0363	CcSEcCtD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDX1—colon cancer	0.00268	0.0388	CbGpPWpGaD
Drospirenone—Thrombosis—Irinotecan—colon cancer	0.00268	0.0329	CcSEcCtD
Drospirenone—PTGS2—endothelium—colon cancer	0.00261	0.0316	CbGeAlD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.0025	0.0362	CbGpPWpGaD
Drospirenone—NR3C2—smooth muscle tissue—colon cancer	0.00243	0.0294	CbGeAlD
Drospirenone—PTGS2—blood vessel—colon cancer	0.00241	0.0291	CbGeAlD
Drospirenone—PGR—epithelium—colon cancer	0.00235	0.0284	CbGeAlD
Drospirenone—NR3C2—renal system—colon cancer	0.00234	0.0283	CbGeAlD
Drospirenone—PTGS2—gall bladder—colon cancer	0.00226	0.0274	CbGeAlD
Drospirenone—PGR—smooth muscle tissue—colon cancer	0.00226	0.0273	CbGeAlD
Drospirenone—PGR—Validated nuclear estrogen receptor alpha network—AXIN2—colon cancer	0.00215	0.0312	CbGpPWpGaD
Drospirenone—PGR—Ovarian Infertility Genes—MLH1—colon cancer	0.00208	0.0301	CbGpPWpGaD
Drospirenone—Loss of libido—Methotrexate—colon cancer	0.00204	0.0251	CcSEcCtD
Drospirenone—Embolism—Capecitabine—colon cancer	0.00197	0.0243	CcSEcCtD
Drospirenone—PGR—Nuclear Receptors—HNF4A—colon cancer	0.00193	0.0279	CbGpPWpGaD
Drospirenone—NR3C2—digestive system—colon cancer	0.00192	0.0232	CbGeAlD
Drospirenone—AR—Integrated Breast Cancer Pathway—RAD54L—colon cancer	0.0019	0.0275	CbGpPWpGaD
Drospirenone—AR—epithelium—colon cancer	0.00187	0.0226	CbGeAlD
Drospirenone—PGR—lymphoid tissue—colon cancer	0.00181	0.0219	CbGeAlD
Drospirenone—AR—smooth muscle tissue—colon cancer	0.0018	0.0218	CbGeAlD
Drospirenone—Thrombosis—Capecitabine—colon cancer	0.00179	0.022	CcSEcCtD
Drospirenone—AR—renal system—colon cancer	0.00173	0.021	CbGeAlD
Drospirenone—NR3C2—vagina—colon cancer	0.0017	0.0205	CbGeAlD
Drospirenone—PGR—vagina—colon cancer	0.00158	0.0191	CbGeAlD
Drospirenone—PGR—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00152	0.022	CbGpPWpGaD
Drospirenone—NR3C2—ACE Inhibitor Pathway—TGFB1—colon cancer	0.00149	0.0215	CbGpPWpGaD
Drospirenone—Embolism—Methotrexate—colon cancer	0.00147	0.0181	CcSEcCtD
Drospirenone—AR—Nuclear Receptors—HNF4A—colon cancer	0.00147	0.0212	CbGpPWpGaD
Drospirenone—BCHE—smooth muscle tissue—colon cancer	0.00147	0.0177	CbGeAlD
Drospirenone—AR—lymphoid tissue—colon cancer	0.00144	0.0174	CbGeAlD
Drospirenone—PTGS2—embryo—colon cancer	0.00144	0.0174	CbGeAlD
Drospirenone—NR3C2—liver—colon cancer	0.00143	0.0173	CbGeAlD
Drospirenone—AR—digestive system—colon cancer	0.00142	0.0172	CbGeAlD
Drospirenone—Cerebrovascular accident—Irinotecan—colon cancer	0.0014	0.0172	CcSEcCtD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—AXIN2—colon cancer	0.00137	0.0199	CbGpPWpGaD
Drospirenone—AR—vagina—colon cancer	0.00126	0.0152	CbGeAlD
Drospirenone—BCHE—Irinotecan Pathway—APC—colon cancer	0.00123	0.0177	CbGpPWpGaD
Drospirenone—PTGS2—epithelium—colon cancer	0.00117	0.0142	CbGeAlD
Drospirenone—AR—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00116	0.0168	CbGpPWpGaD
Drospirenone—BCHE—digestive system—colon cancer	0.00116	0.014	CbGeAlD
Drospirenone—AR—Integrated Breast Cancer Pathway—ODC1—colon cancer	0.00115	0.0166	CbGpPWpGaD
Drospirenone—PTGS2—smooth muscle tissue—colon cancer	0.00113	0.0137	CbGeAlD
Drospirenone—NR3C2—lymph node—colon cancer	0.0011	0.0133	CbGeAlD
Drospirenone—PTGS2—renal system—colon cancer	0.00109	0.0131	CbGeAlD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00109	0.0157	CbGpPWpGaD
Drospirenone—Depression—Vincristine—colon cancer	0.00108	0.0133	CcSEcCtD
Drospirenone—Acute coronary syndrome—Vincristine—colon cancer	0.00107	0.0132	CcSEcCtD
Drospirenone—BCHE—bone marrow—colon cancer	0.00107	0.0129	CbGeAlD
Drospirenone—Myocardial infarction—Vincristine—colon cancer	0.00107	0.0131	CcSEcCtD
Drospirenone—AR—liver—colon cancer	0.00106	0.0128	CbGeAlD
Drospirenone—Acute coronary syndrome—Irinotecan—colon cancer	0.00104	0.0128	CcSEcCtD
Drospirenone—Myocardial infarction—Irinotecan—colon cancer	0.00104	0.0128	CcSEcCtD
Drospirenone—BCHE—vagina—colon cancer	0.00102	0.0124	CbGeAlD
Drospirenone—PGR—lymph node—colon cancer	0.00102	0.0123	CbGeAlD
Drospirenone—Acute coronary syndrome—Fluorouracil—colon cancer	0.001	0.0123	CcSEcCtD
Drospirenone—BCHE—Peptide hormone metabolism—CDX2—colon cancer	0.000999	0.0145	CbGpPWpGaD
Drospirenone—Myocardial infarction—Fluorouracil—colon cancer	0.000995	0.0122	CcSEcCtD
Drospirenone—Haemoglobin—Irinotecan—colon cancer	0.000956	0.0117	CcSEcCtD
Drospirenone—Haemorrhage—Irinotecan—colon cancer	0.000951	0.0117	CcSEcCtD
Drospirenone—Cerebrovascular accident—Capecitabine—colon cancer	0.000939	0.0115	CcSEcCtD
Drospirenone—NR3C2—Preimplantation Embryo—CDH1—colon cancer	0.000933	0.0135	CbGpPWpGaD
Drospirenone—Haemoglobin—Fluorouracil—colon cancer	0.000916	0.0113	CcSEcCtD
Drospirenone—Haemorrhage—Fluorouracil—colon cancer	0.000911	0.0112	CcSEcCtD
Drospirenone—Migraine—Capecitabine—colon cancer	0.000906	0.0111	CcSEcCtD
Drospirenone—PTGS2—lymphoid tissue—colon cancer	0.000902	0.0109	CbGeAlD
Drospirenone—PTGS2—digestive system—colon cancer	0.000891	0.0108	CbGeAlD
Drospirenone—Angiopathy—Vincristine—colon cancer	0.000886	0.0109	CcSEcCtD
Drospirenone—Mood swings—Capecitabine—colon cancer	0.000872	0.0107	CcSEcCtD
Drospirenone—PTGS2—Overview of nanoparticle effects—BAX—colon cancer	0.000867	0.0126	CbGpPWpGaD
Drospirenone—Angiopathy—Irinotecan—colon cancer	0.000863	0.0106	CcSEcCtD
Drospirenone—BCHE—liver—colon cancer	0.000862	0.0104	CbGeAlD
Drospirenone—Mental disorder—Vincristine—colon cancer	0.000856	0.0105	CcSEcCtD
Drospirenone—PGR—Nuclear Receptors—PPARG—colon cancer	0.000836	0.0121	CbGpPWpGaD
Drospirenone—Breast disorder—Capecitabine—colon cancer	0.000831	0.0102	CcSEcCtD
Drospirenone—PTGS2—bone marrow—colon cancer	0.000822	0.00994	CbGeAlD
Drospirenone—AR—lymph node—colon cancer	0.000812	0.00983	CbGeAlD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—HNF4A—colon cancer	0.000801	0.0116	CbGpPWpGaD
Drospirenone—PTGS2—vagina—colon cancer	0.000787	0.00952	CbGeAlD
Drospirenone—Depression—Capecitabine—colon cancer	0.000707	0.00869	CcSEcCtD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000702	0.0102	CbGpPWpGaD
Drospirenone—Acute coronary syndrome—Capecitabine—colon cancer	0.000699	0.00859	CcSEcCtD
Drospirenone—Cerebrovascular accident—Methotrexate—colon cancer	0.000699	0.00859	CcSEcCtD
Drospirenone—Myocardial infarction—Capecitabine—colon cancer	0.000695	0.00854	CcSEcCtD
Drospirenone—Nervous system disorder—Vincristine—colon cancer	0.00068	0.00836	CcSEcCtD
Drospirenone—PTGS2—liver—colon cancer	0.000664	0.00803	CbGeAlD
Drospirenone—Nervous system disorder—Irinotecan—colon cancer	0.000663	0.00814	CcSEcCtD
Drospirenone—BCHE—lymph node—colon cancer	0.000661	0.00799	CbGeAlD
Drospirenone—PGR—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.000661	0.00957	CbGpPWpGaD
Drospirenone—Mood swings—Methotrexate—colon cancer	0.000649	0.00798	CcSEcCtD
Drospirenone—Haemoglobin—Capecitabine—colon cancer	0.00064	0.00786	CcSEcCtD
Drospirenone—AR—Nuclear Receptors—PPARG—colon cancer	0.000637	0.00922	CbGpPWpGaD
Drospirenone—Haemorrhage—Capecitabine—colon cancer	0.000637	0.00782	CcSEcCtD
Drospirenone—Nervous system disorder—Fluorouracil—colon cancer	0.000635	0.0078	CcSEcCtD
Drospirenone—AR—Integrated Breast Cancer Pathway—MSH6—colon cancer	0.000626	0.00906	CbGpPWpGaD
Drospirenone—Breast disorder—Methotrexate—colon cancer	0.000619	0.00761	CcSEcCtD
Drospirenone—Erythema multiforme—Capecitabine—colon cancer	0.000602	0.0074	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Vincristine—colon cancer	0.000599	0.00736	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Irinotecan—colon cancer	0.000583	0.00717	CcSEcCtD
Drospirenone—Angiopathy—Capecitabine—colon cancer	0.000578	0.0071	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000559	0.00687	CcSEcCtD
Drospirenone—Mental disorder—Capecitabine—colon cancer	0.000558	0.00685	CcSEcCtD
Drospirenone—Depression—Methotrexate—colon cancer	0.000526	0.00647	CcSEcCtD
Drospirenone—PTGS2—lymph node—colon cancer	0.000509	0.00616	CbGeAlD
Drospirenone—AR—Integrated Breast Cancer Pathway—MSH2—colon cancer	0.000508	0.00735	CbGpPWpGaD
Drospirenone—AR—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.000503	0.00729	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000479	0.00694	CbGpPWpGaD
Drospirenone—AR—Nongenotropic Androgen signaling—SRC—colon cancer	0.000477	0.00691	CbGpPWpGaD
Drospirenone—Haemoglobin—Methotrexate—colon cancer	0.000476	0.00585	CcSEcCtD
Drospirenone—Haemorrhage—Methotrexate—colon cancer	0.000474	0.00582	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000469	0.00576	CcSEcCtD
Drospirenone—Megestrol acetate—ABCB1—colon cancer	0.000457	0.306	CrCbGaD
Drospirenone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—colon cancer	0.000453	0.00656	CbGpPWpGaD
Drospirenone—Erythema multiforme—Methotrexate—colon cancer	0.000448	0.00551	CcSEcCtD
Drospirenone—Nervous system disorder—Capecitabine—colon cancer	0.000443	0.00545	CcSEcCtD
Drospirenone—Skin disorder—Capecitabine—colon cancer	0.000439	0.0054	CcSEcCtD
Drospirenone—NR3C2—Generic Transcription Pathway—HNF4A—colon cancer	0.000432	0.00625	CbGpPWpGaD
Drospirenone—Angiopathy—Methotrexate—colon cancer	0.00043	0.00528	CcSEcCtD
Drospirenone—Mental disorder—Methotrexate—colon cancer	0.000415	0.0051	CcSEcCtD
Drospirenone—Nausea—Vincristine—colon cancer	0.000412	0.00507	CcSEcCtD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000404	0.00584	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000403	0.00584	CbGpPWpGaD
Drospirenone—Nausea—Irinotecan—colon cancer	0.000401	0.00493	CcSEcCtD
Drospirenone—PTGS2—S1P1 pathway—VEGFA—colon cancer	0.000395	0.00572	CbGpPWpGaD
Drospirenone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—colon cancer	0.000392	0.00567	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Capecitabine—colon cancer	0.00039	0.0048	CcSEcCtD
Drospirenone—Nausea—Fluorouracil—colon cancer	0.000384	0.00472	CcSEcCtD
Drospirenone—AR—FOXA1 transcription factor network—EP300—colon cancer	0.000371	0.00537	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—colon cancer	0.000364	0.00527	CbGpPWpGaD
Drospirenone—AR—Nongenotropic Androgen signaling—PIK3CA—colon cancer	0.000363	0.00525	CbGpPWpGaD
Drospirenone—PGR—Validated nuclear estrogen receptor alpha network—EP300—colon cancer	0.000361	0.00522	CbGpPWpGaD
Drospirenone—AR—Notch-mediated HES/HEY network—EP300—colon cancer	0.000352	0.00509	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000349	0.00429	CcSEcCtD
Drospirenone—AR—Nongenotropic Androgen signaling—HRAS—colon cancer	0.000336	0.00486	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—colon cancer	0.000335	0.00485	CbGpPWpGaD
Drospirenone—Nervous system disorder—Methotrexate—colon cancer	0.00033	0.00406	CcSEcCtD
Drospirenone—Skin disorder—Methotrexate—colon cancer	0.000327	0.00402	CcSEcCtD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000322	0.00467	CbGpPWpGaD
Drospirenone—AR—Regulation of Androgen receptor activity—EP300—colon cancer	0.000319	0.00462	CbGpPWpGaD
Drospirenone—PGR—Validated nuclear estrogen receptor alpha network—MYC—colon cancer	0.000314	0.00455	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—FGFR3—colon cancer	0.000311	0.00451	CbGpPWpGaD
Drospirenone—AR—Regulation of Androgen receptor activity—SRC—colon cancer	0.000311	0.0045	CbGpPWpGaD
Drospirenone—AR—Coregulation of Androgen receptor activity—CCND1—colon cancer	0.00031	0.00449	CbGpPWpGaD
Drospirenone—AR—Coregulation of Androgen receptor activity—CTNNB1—colon cancer	0.000307	0.00445	CbGpPWpGaD
Drospirenone—AR—Nongenotropic Androgen signaling—AKT1—colon cancer	0.000296	0.00429	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—colon cancer	0.000294	0.00426	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Methotrexate—colon cancer	0.000291	0.00357	CcSEcCtD
Drospirenone—AR—Integrated Breast Cancer Pathway—BAX—colon cancer	0.000287	0.00416	CbGpPWpGaD
Drospirenone—Spironolactone—ABCB1—colon cancer	0.000284	0.19	CrCbGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000275	0.00399	CbGpPWpGaD
Drospirenone—Nausea—Capecitabine—colon cancer	0.000269	0.0033	CcSEcCtD
Drospirenone—Norethindrone—ABCB1—colon cancer	0.000264	0.177	CrCbGaD
Drospirenone—PGR—Generic Transcription Pathway—HNF4A—colon cancer	0.000263	0.00381	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000252	0.00364	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—colon cancer	0.00025	0.00361	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—colon cancer	0.000247	0.00358	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000247	0.00358	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CA7—colon cancer	0.000244	0.00353	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.000239	0.00346	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000238	0.00345	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000232	0.00336	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—colon cancer	0.00023	0.00333	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—CCND1—colon cancer	0.000229	0.00332	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	0.000228	0.00329	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—CTNNB1—colon cancer	0.000227	0.00329	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—CDKN1A—colon cancer	0.000222	0.00321	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	0.000216	0.00313	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—colon cancer	0.000215	0.00311	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—EP300—colon cancer	0.000211	0.00305	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—HNF4A—colon cancer	0.000208	0.00301	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—DLC1—colon cancer	0.000207	0.00299	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.000206	0.00298	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—EP300—colon cancer	0.000206	0.00298	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—SRC—colon cancer	0.000205	0.00297	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.000201	0.00292	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—HNF4A—colon cancer	0.0002	0.0029	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—colon cancer	0.0002	0.0029	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—SRC—colon cancer	0.0002	0.0029	CbGpPWpGaD
Drospirenone—Nausea—Methotrexate—colon cancer	0.0002	0.00246	CcSEcCtD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	0.000198	0.00287	CbGpPWpGaD
Drospirenone—BCHE—Peptide hormone metabolism—CTNNB1—colon cancer	0.000197	0.00285	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	0.000195	0.00282	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LGR5—colon cancer	0.000194	0.00281	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	0.000192	0.00279	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—CDKN1A—colon cancer	0.00019	0.00275	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CDX2—colon cancer	0.000189	0.00273	CbGpPWpGaD
Drospirenone—Hydrocortisone—ABCB1—colon cancer	0.000189	0.126	CrCbGaD
Drospirenone—NR3C2—Generic Transcription Pathway—PPARG—colon cancer	0.000187	0.00271	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000185	0.00268	CbGpPWpGaD
Drospirenone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—colon cancer	0.000183	0.00265	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000181	0.00263	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—EGFR—colon cancer	0.00018	0.0026	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—MYC—colon cancer	0.000179	0.00259	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	0.000175	0.00254	CbGpPWpGaD
Drospirenone—AR—Coregulation of Androgen receptor activity—AKT1—colon cancer	0.000172	0.0025	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—NRAS—colon cancer	0.000169	0.00244	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CA7—colon cancer	0.000168	0.00243	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	0.000166	0.0024	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MUC2—colon cancer	0.00016	0.00232	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.000154	0.00223	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—EGFR—colon cancer	0.000154	0.00223	CbGpPWpGaD
Drospirenone—Progesterone—ABCB1—colon cancer	0.000154	0.103	CrCbGaD
Drospirenone—AR—SIDS Susceptibility Pathways—CASP3—colon cancer	0.00015	0.00218	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.00015	0.00217	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.000149	0.00215	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ODC1—colon cancer	0.000148	0.00214	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CHST5—colon cancer	0.000148	0.00214	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—KRAS—colon cancer	0.000145	0.0021	CbGpPWpGaD
Drospirenone—Testosterone—ABCB1—colon cancer	0.000145	0.0974	CrCbGaD
Drospirenone—AR—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000145	0.0021	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000145	0.00209	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000142	0.00206	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	0.000141	0.00204	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AXIN2—colon cancer	0.00014	0.00202	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—EP300—colon cancer	0.000138	0.002	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—CCND1—colon cancer	0.000138	0.002	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000138	0.00199	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	0.000137	0.00199	CbGpPWpGaD
Drospirenone—BCHE—Transmission across Chemical Synapses—BRAF—colon cancer	0.000137	0.00199	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000137	0.00198	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—EP300—colon cancer	0.000135	0.00195	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—CDKN1A—colon cancer	0.000134	0.00193	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—PIK3CA—colon cancer	0.000134	0.00193	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.000131	0.0019	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000128	0.00185	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.000128	0.00185	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—AKT1—colon cancer	0.000128	0.00185	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—EP300—colon cancer	0.000127	0.00184	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—HNF4A—colon cancer	0.000127	0.00183	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000124	0.0018	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—HRAS—colon cancer	0.000124	0.00179	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000123	0.00178	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CHST5—colon cancer	0.000122	0.00176	CbGpPWpGaD
Drospirenone—PTGS2—Disease—LGR5—colon cancer	0.000122	0.00176	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—MYC—colon cancer	0.00012	0.00174	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.00012	0.00174	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—NRAS—colon cancer	0.000119	0.00172	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.000118	0.00171	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000115	0.00166	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—PPARG—colon cancer	0.000114	0.00165	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000111	0.00161	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.000111	0.00161	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—MYC—colon cancer	0.000111	0.0016	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—AKT1—colon cancer	0.000109	0.00158	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000108	0.00157	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CASP3—colon cancer	0.000108	0.00156	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—MYC—colon cancer	0.000107	0.00155	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—BRAF—colon cancer	0.000105	0.00152	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CCND1—colon cancer	0.000105	0.00152	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000104	0.00151	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—KRAS—colon cancer	0.000102	0.00148	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CHST5—colon cancer	0.000102	0.00147	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ODC1—colon cancer	0.000102	0.00147	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	9.98e-05	0.00145	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	9.96e-05	0.00144	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—TP53—colon cancer	9.89e-05	0.00143	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	9.76e-05	0.00141	CbGpPWpGaD
Drospirenone—AR—Gene Expression—HNF4A—colon cancer	9.64e-05	0.0014	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	9.22e-05	0.00134	CbGpPWpGaD
Drospirenone—BCHE—Phospholipid metabolism—PIK3CA—colon cancer	9.18e-05	0.00133	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—PPARG—colon cancer	9.02e-05	0.00131	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AXIN2—colon cancer	8.73e-05	0.00126	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—PPARG—colon cancer	8.7e-05	0.00126	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—HRAS—colon cancer	8.7e-05	0.00126	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	8.47e-05	0.00123	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MYC—colon cancer	8.44e-05	0.00122	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TGFB1—colon cancer	8.42e-05	0.00122	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—AKT1—colon cancer	8.35e-05	0.00121	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—EGFR—colon cancer	8.25e-05	0.00119	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	8.2e-05	0.00119	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	7.35e-05	0.00106	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	7.15e-05	0.00104	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	7.08e-05	0.00103	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TP53—colon cancer	6.93e-05	0.001	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	6.92e-05	0.001	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	6.92e-05	0.001	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	6.59e-05	0.000953	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—MYC—colon cancer	6.51e-05	0.000942	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	6.4e-05	0.000927	CbGpPWpGaD
Drospirenone—BCHE—Transmission across Chemical Synapses—HRAS—colon cancer	6.31e-05	0.000914	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	6.24e-05	0.000903	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.11e-05	0.000884	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	5.74e-05	0.000831	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	5.72e-05	0.000829	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	5.61e-05	0.000813	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PPARG—colon cancer	5.5e-05	0.000796	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	5.3e-05	0.000768	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MYC—colon cancer	5.14e-05	0.000745	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—MYC—colon cancer	4.96e-05	0.000718	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	4.87e-05	0.000705	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—HRAS—colon cancer	4.84e-05	0.0007	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.8e-05	0.000695	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	4.71e-05	0.000682	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.2e-05	0.000609	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PPARG—colon cancer	4.19e-05	0.000606	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGFR3—colon cancer	4.03e-05	0.000584	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—EP300—colon cancer	4e-05	0.000578	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	3.98e-05	0.000576	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ABCB1—colon cancer	3.91e-05	0.000566	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—TYMS—colon cancer	3.84e-05	0.000556	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CTNNB1—colon cancer	3.71e-05	0.000538	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APC—colon cancer	3.7e-05	0.000536	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—AKT1—colon cancer	3.57e-05	0.000516	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—BRAF—colon cancer	3.48e-05	0.000504	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MYC—colon cancer	3.13e-05	0.000454	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.96e-05	0.000428	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.75e-05	0.000398	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPARG—colon cancer	2.72e-05	0.000394	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ABCB1—colon cancer	2.69e-05	0.00039	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—TYMS—colon cancer	2.64e-05	0.000383	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CASP3—colon cancer	2.61e-05	0.000378	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCND1—colon cancer	2.54e-05	0.000368	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGFR3—colon cancer	2.52e-05	0.000365	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CTNNB1—colon cancer	2.51e-05	0.000364	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN1A—colon cancer	2.46e-05	0.000356	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MYC—colon cancer	2.39e-05	0.000346	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EP300—colon cancer	2.34e-05	0.000338	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APC—colon cancer	2.32e-05	0.000335	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SRC—colon cancer	2.27e-05	0.000329	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VEGFA—colon cancer	2.21e-05	0.000321	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NRAS—colon cancer	2.19e-05	0.000317	CbGpPWpGaD
Drospirenone—PTGS2—Disease—BRAF—colon cancer	2.18e-05	0.000315	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—AKT1—colon cancer	2.17e-05	0.000315	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS2—colon cancer	2.14e-05	0.00031	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MYC—colon cancer	2.04e-05	0.000295	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.03e-05	0.000295	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TGFB1—colon cancer	2.03e-05	0.000294	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EGFR—colon cancer	1.99e-05	0.000288	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KRAS—colon cancer	1.88e-05	0.000273	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPARG—colon cancer	1.87e-05	0.000271	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—EP300—colon cancer	1.78e-05	0.000258	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CA—colon cancer	1.73e-05	0.00025	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TP53—colon cancer	1.67e-05	0.000242	CbGpPWpGaD
Drospirenone—AR—Gene Expression—AKT1—colon cancer	1.66e-05	0.00024	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HRAS—colon cancer	1.6e-05	0.000232	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CTNNB1—colon cancer	1.57e-05	0.000228	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN1A—colon cancer	1.54e-05	0.000223	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EP300—colon cancer	1.46e-05	0.000212	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SRC—colon cancer	1.42e-05	0.000206	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKT1—colon cancer	1.41e-05	0.000205	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NRAS—colon cancer	1.37e-05	0.000198	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CA—colon cancer	1.32e-05	0.000191	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MYC—colon cancer	1.27e-05	0.000184	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFB1—colon cancer	1.27e-05	0.000184	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EGFR—colon cancer	1.25e-05	0.00018	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—EP300—colon cancer	1.22e-05	0.000177	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KRAS—colon cancer	1.18e-05	0.00017	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CA—colon cancer	1.08e-05	0.000157	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKT1—colon cancer	1.08e-05	0.000156	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HRAS—colon cancer	1e-05	0.000145	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CA—colon cancer	9.06e-06	0.000131	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKT1—colon cancer	8.84e-06	0.000128	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKT1—colon cancer	7.4e-06	0.000107	CbGpPWpGaD
